WHAT COULD 
MEAN FOR YOUR TREATMENT JOURNEY?
SAPHNELO® IS COVERED BY MOST PUBLIC PLANS ACROSS CANADA (CRITERIA MAY APPLY)‡
Download this discussion guide to help facilitate conversations with your healthcare professional about what SAPHNELO® could do for you and your treatment plan.
DownloadDO YOU ALREADY HAVE A PRESCRIPTION FOR SAPHNELO®?
To enter the patient website, please enter the 8-digit DIN (Drug Identification Number).
.png)
+ Intravenous infusion format is also available.
‡ Public coverage is available through participating provincial, territorial, and federal programs, including the Non-Insured Health Benefits (NIHB) Program, in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Ontario, Prince Edward Island, Quebec, and Saskatchewan. Coverage is subject to applicable reimbursement criteria.
SAPHNELO® and the AstraZeneca logo are registered trademarks of AstraZeneca AB, used under license by AstraZeneca Canada Inc. © AstraZeneca Canada Inc. 2026
what is DIN
Your DIN is the 8-digit number
located on the product box here.
Your DIN is also on the back page of the
patient brochure you may have received.
